News

LAG-3 represents a potentially relevant immune checkpoint pathway in melanoma treatment.

An expert from Seattle Cancer Care Alliance highlights key skills in nurse navigation.

An expert from The University of Texas MD Anderson Cancer Center highlights findings demonstrating the impact that diet and probiotics have in immunotherapy responses.

Compared with other antibody-drug conjugates, datopotamab deruxtecan was associated with lower rates of neutropenia, pneumonitis, and hematologic toxicity.

An expert from the Tisch Cancer Institute highlights the importance of medication adherence, nausea management, and proper hydration for patients being treated with selinexor for relapsed or refractory multiple myeloma.

The chair of the Institute of Pain and Palliative Care explains how the holistic approach of palliative care makes it a unique treatment modality.

David Hui, MD, MSc, from The University of Texas MD Anderson Cancer Center, discusses findings indicating that patients with agitated delirium may be under-sedated, in accordance with their personalized sedation goal.

Kathy Burns, MS, APRN-CNS, AGCNS-BC, of the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, comments on the importance of self-awareness as an oncology nurse when working to overcome one’s implicit bias.

Jessica MacIntyre, APRN, NP-C, AOCNP, explains how Hematology/Oncology Nurse Practitioner Fellowship at Sylvester Comprehensive Cancer Center prepares fellows for success.

The chair of the Institute of Pain and Palliative Care explains how patients with cancer may improve their treatment outcomes with palliative care.

The chair of the Institute of Pain and Palliative Care explains the primary difference between hospice and palliative care.

Kathy Burns, MS, APRN-CNS, AGCNS-BC, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, comments on the importance of being mindful about one’s implicit bias in the treatment of patients with cancer who have substance use disorders.

David Hui, MD, MSc, from The University of Texas MD Anderson Cancer Center, discusses how caregivers may prioritize communication when making end-of-life sedation decisions for loved ones with agitated delirium.

“Each step along the way has really helped me grow professionally, not just as a clinician, but as a whole practitioner, to make my transition to practice a lot easier and make me more comfortable… it’s really an invaluable experience.”

Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN, Oncology Nursing News co-editor in chief, discusses the importance of NCCN guidelines in prescribing medications for patients with chronic leukemia. .

Jessica MacIntyre, executive director of clinical operations at Sylvester Comprehensive Cancer Center, explains how the small market for experienced oncology nurse practitioners prompted their institution to design a successful Hematology/Oncology Nurse Practitioner Fellowship.

The director at the Center for Cancer Health Equity, The University of Ohio Comprehensive Cancer Center, discusses how the pandemic put a spotlight on issues of equity within the health care system.

Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN, Oncology Nursing News co-editor in chief, discusses omacetaxine as a novel regimen in CML treatment.

A survey completed by nurses and APPs revealed that many healthcare professionals may be blind to their own implicit biases.

The director at the Center for Cancer Health Equity, The University of Ohio Comprehensive Cancer Center, discusses improving preventative screenings in underprivileged communities.

Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN, Oncology Nursing News co-editor in chief, comments on how health care providers can effectively care for patients with COVID-19 and hematologic malignancies.

Answering questions without judgement and showcasing community members who have received the COVID-19 vaccine without negative outcomes can help alleiviate vaccine-related fears and concerns in BIPOC patients with cancer.

Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN, Oncology Nursing News co-editor in chief, comments on the dedication she has observed from caregivers taking care of loved ones with leukemia during the COVID-19 era.

Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN, Oncology Nursing News Co-Editor in Chief, shares her opinion on recent developments in leukemia treatment options.

Between monitoring for medication adherence and ensuring that patients know when to call if their symptoms escalate, oncology nurses are a pivotal factor in decreasing mortality among patients with leukemia, says Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN.

Chevon Rariy, MD, outlines patient eligibility criteria, and the alterations to the nurse patient relationship, as CTCA launches the novel Oncology Clinic at Home Program.

Nagla Abdel Karim, MD, explains how researchers will address safety and manage potential adverse events in the ongoing phase 3 CheckMate-73L trial.

“There were delays in getting preventative screenings, there were delay in diagnostics, there was also a brief period of time when some of the clinical trials were shut down.”

Kelly L. Garvin, BSN, RN, OCN, discusses what changes she hopes to see in CAR T-Cell therapy treatment over the coming years.

“More than 90% of serotonin receptors and serotonin is made in the gut.”